We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Interdisciplinary Research Center Targets the Microbiome

By LabMedica International staff writers
Posted on 19 Nov 2014
An interdisciplinary research center has been established to promote studies on the microbiome, the many communities of microorganisms living within the human body, and its relation to human health and disease.

The Center for Microbiome Informatics and Therapeutics (CMIT) is a New England (USA) regional center to advance the science of the human microbiome and the treatment of conditions and diseases associated with an altered microbiome. More...
Located at the Massachusetts Institute of Technology (Cambridge, USA), with co-directors from the Massachusetts Institute of Technology and Massachusetts General Hospital (Boston, USA), the center is dedicated to fostering and supporting a research ecosystem involving the participation of hospitals, other universities, and research institutes in the region. The center is being launched with an initial 25 million USD expendable budget over five years, and the first requests for proposals will be released in January 2015.

The center has three core functions: to advance the field by funding research proposals; to help individual research projects proceed more efficiently through shared services, such as a regional sample facility or support for regulatory compliance; and to draw new talent to microbiome research by promoting the field within the academic community. The center focuses on supporting the intersection of research, clinical practice, computational biology, and engineering.

One of the center co-directors, Dr. Ramnik Xavier, chief of gastroenterology at Massachusetts General Hospital, said, “Molecular biologists, microbiologists, and cell biologists seek to understand microbe/microbe and microbe/host cell function and communication. Immunologists, geneticists, and genomics researchers drive progress. To this wealth of information, clinicians contribute patient-based insights and gain potential targets for therapeutics. We want this center to be a convening hub for strengths that are distributed across disciplines and throughout different institutions in the New England region.”

Related Links:

Massachusetts Institute of Technology
Massachusetts General Hospital



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Rapid Test Reader
DIA5000
New
Host Response Immunoassay Test
MeMed BV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.